Study: NCT01717157

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: DUROGESIC (8.4 mg fentanyl)
Description: One DUROGESIC transdermal patch containing 8.4 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: DUROGESIC (8.4 mg fentanyl)
Description: One DUROGESIC transdermal patch containing 8.4 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: DUROGESIC (8.4 mg fentanyl)
Description: One DUROGESIC transdermal patch containing 8.4 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: DUROGESIC (8.4 mg fentanyl)
Description: One DUROGESIC transdermal patch containing 8.4 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: DUROGESIC (8.4 mg fentanyl)
Description: One DUROGESIC transdermal patch containing 8.4 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: DUROGESIC (8.4 mg fentanyl)
Description: One DUROGESIC transdermal patch containing 8.4 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: DUROGESIC (8.4 mg fentanyl)
Description: One DUROGESIC transdermal patch containing 8.4 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A: DUROGESIC (8.4 mg fentanyl)
Description: One DUROGESIC transdermal patch containing 8.4 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: Transdermal System-Concept 1 (6.2 mg fentanyl)
Description: One transdermal system-concept 1 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: Transdermal System-Concept 1 (6.2 mg fentanyl)
Description: One transdermal system-concept 1 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: Transdermal System-Concept 1 (6.2 mg fentanyl)
Description: One transdermal system-concept 1 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: Transdermal System-Concept 1 (6.2 mg fentanyl)
Description: One transdermal system-concept 1 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: Transdermal System-Concept 1 (6.2 mg fentanyl)
Description: One transdermal system-concept 1 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B: Transdermal System-Concept 1 (6.2 mg fentanyl)
Description: One transdermal system-concept 1 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: Transdermal System-Concept 2 (6.2 mg fentanyl)
Description: One transdermal system-concept 2 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: Transdermal System-Concept 2 (6.2 mg fentanyl)
Description: One transdermal system-concept 2 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: Transdermal System-Concept 2 (6.2 mg fentanyl)
Description: One transdermal system-concept 2 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: Transdermal System-Concept 2 (6.2 mg fentanyl)
Description: One transdermal system-concept 2 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: Transdermal System-Concept 2 (6.2 mg fentanyl)
Description: One transdermal system-concept 2 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C: Transdermal System-Concept 2 (6.2 mg fentanyl)
Description: One transdermal system-concept 2 patch containing approximately 6.2 mg of fentanyl applied on the skin for 72 hours.